A 64-year-old man with type 2 diabetes, albuminuric chronic kidney disease (eGFR 45 mL/min/1.73 m²) and prior MI has an A1C of 7.5% on metformin and b...

Question

A 64-year-old man with type 2 diabetes, albuminuric chronic kidney disease (eGFR 45 mL/min/1.73 m²) and prior MI has an A1C of 7.5% on metformin and basal insulin. Which additional agent is most strongly recommended to reduce cardiovascular and renal outcomes?

Accepted Answer

GLP-1 receptor agonist with proven cardiovascular benefit

Answer

DPP-4 inhibitor

Answer

Sulfonylurea

Answer

Thiazolidinedione

Answer

Alpha-glucosidase inhibitor

ca-mccqe1 MCQ (SBA): Type 2 diabetes with ASCVD and CKD

A 64-year-old man with type 2 diabetes, albuminuric chronic kidney disease (eGFR 45 mL/min/1.73 m²) and prior MI has an A1C of 7.5% on metformin and basal insulin. Which additional agent is most strongly recommended to reduce cardiovascular and renal outcomes?